CRESTONE INC has a total of 11 patent applications. Its first patent ever was published in 2007. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ACQUIST LLC, CHANGZHOU JIEKAI PHARMATECH CO LTD and EISAI LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 3 | |
#3 | Australia | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Sun Xicheng | 11 |
#2 | Strong Sarah | 8 |
#3 | Guiles Joseph | 8 |
#4 | Janjic Nebojsa | 7 |
#5 | Gyorkos Albert Charles | 5 |
#6 | Graham James | 3 |
#7 | Wong Christina | 3 |
#8 | Day Joshua | 3 |
#9 | Jarvis Thale | 2 |
#10 | Mcfaddin Elizabeth | 2 |
Publication | Filing date | Title |
---|---|---|
US2021002239A1 | Novel Antimycobacterial Heterocyclic Amides | |
EP2200440A1 | Antibacterial amide and sulfonamide substituted heterocyclic urea compounds | |
US2008146609A1 | Substituted thienopyridone compounds with antibacterial activity | |
EP2094714A2 | Substituted thienopyridone compounds with antibacterial activity | |
US2008108651A1 | Enantiomeric compounds with antibacterial activity | |
AU2007300290A1 | Enantiomeric compounds with antibacterial activity |